Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Written Exposure Therapy for Veterans with Substance Use Disorders and PTSD

Official title: Written Exposure Therapy (WET) as a Brief Trauma Treatment for Veterans With Co-occurring Substance Use Disorders and PTSD

Run by VA Office of Research and Development · NCT05327504 · Data updated 2026-11-12

This study is testing if written exposure therapy can help veterans with substance use disorders and PTSD feel better and improve their recovery compared to a standard treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (West Haven, Connecticut)
StatusRecruiting
StartedSeptember 26, 2022
Main results expectedMay 12, 2027
Study endsJune 30, 2027
Registry record updatedFebruary 19, 2026
Trial IDNCT05327504 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Veterans aged 18 and older who have a diagnosis of both substance use disorder and PTSD.

Probably not a fit

Patients with schizophrenia, severe mood disorders, or those who have recently undergone specific PTSD therapies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project evaluates the effectiveness of written exposure therapy (WET) for Veterans undergoing treatment for substance use disorders (SUD) who also have posttraumatic stress disorder (PTSD). The study involves a randomized clinical trial where participants will receive either WET combined with standard treatment or a neutral writing condition alongside standard treatment. The aim is to determine if WET can significantly reduce PTSD symptoms and improve addiction outcomes compared to the control group. Assessments will be conducted at multiple time points to measure changes in trauma symptoms, distress, and mood.

Why it matters

Potential benefit: If successful, this therapy could provide Veterans with a novel and effective approach to simultaneously address both PTSD and substance use disorders.

How similar studies have gone: Previous studies have shown promising results for written exposure therapy in similar populations, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Veterans ages 18 years old or older;
* Meets DSM-5 criteria for at least one substance use disorder (SUD);
* Meets DSM-5 criteria for PTSD;
* Approved for SUD treatment at VA Connecticut Healthcare System.

Exclusion Criteria:

* Veterans who meet current criteria for schizophrenia, schizophrenia-type disorders, or unmedicated mania or bipolar disorder as determined by QuickSCID-5;
* current suicidal or homicidal risks necessitating a higher level of care;
* Veterans who have received an Evidence-Based Psychotherapy for PTSD protocol within the past 6 months;
* Problems that would prevent a participant from completing the writing intervention or study assessments (e.g., illiteracy). To assess for literacy, participants will read parts of the consent out loud.

Where it's running

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT
    West Haven, Connecticut, United States
    Recruiting

Study contacts

  • Principal investigator: Sarah Meshberg-Cohen, PhD MS BS — VA Connecticut Healthcare System West Haven Campus, West Haven, CT
  • Study coordinator: Vera Bici, BA
  • Email: Vera.Bici@va.gov
  • Phone: (203) 932-5711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.